The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4,11-Dimethoxy-14-methyl-7,8,13b,14-tetrahydroindolo-[2',3':3,4]pyrido[2,1-b]quinazolin-5(13H)-one ID: ALA4783742
PubChem CID: 162665444
Max Phase: Preclinical
Molecular Formula: C21H21N3O3
Molecular Weight: 363.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2c3c([nH]c2c1)C1N(CC3)C(=O)c2c(OC)cccc2N1C
Standard InChI: InChI=1S/C21H21N3O3/c1-23-16-5-4-6-17(27-3)18(16)21(25)24-10-9-14-13-8-7-12(26-2)11-15(13)22-19(14)20(23)24/h4-8,11,20,22H,9-10H2,1-3H3
Standard InChI Key: WNMIZGXEPWFQCU-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
14.7553 -8.6438 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4129 -9.3856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8864 -10.0525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5481 -10.7943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0216 -11.4612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8333 -11.3863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1757 -10.6404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7022 -9.9735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0405 -9.2317 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8564 -9.1568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7323 -10.8734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3940 -11.6152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2588 -10.2065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6012 -9.4605 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1278 -8.7977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3119 -8.8726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4471 -10.2814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9736 -9.6144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1923 -9.8606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4900 -9.4446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7784 -9.8457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7692 -10.6629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0577 -11.0640 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3553 -10.6481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4716 -11.0788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1832 -10.6777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9603 -10.9367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
3 8 1 0
8 9 1 0
9 10 1 0
4 11 1 0
11 12 1 0
11 13 1 0
13 14 1 0
2 14 1 0
14 15 1 0
15 16 1 0
13 17 1 0
17 18 2 0
16 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
22 25 1 0
25 26 2 0
19 26 1 0
26 27 1 0
17 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 363.42Molecular Weight (Monoisotopic): 363.1583AlogP: 3.33#Rotatable Bonds: 2Polar Surface Area: 57.80Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.00CX LogD: 3.00Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: 0.23
References 1. Zhang T,Lai Z,Yuan S,Huang YY,Dong G,Sheng C,Ke H,Luo HB. (2020) Discovery of Evodiamine Derivatives as Highly Selective PDE5 Inhibitors Targeting a Unique Allosteric Pocket., 63 (17): [PMID:32794708 ] [10.1021/acs.jmedchem.0c00983 ]